Glesatinib hydrochloride
Cat. No.: IBDI-436161
Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. Glesatinib hydrochloride, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).
Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution
Online Inquiry
Size (Solid):
Online Inquiry
Product Details
| Target |
TAM Receptor | c-Met/HGFR |
| Molecular Weight |
656.17 |
| Appearance |
Solid |
| Synonyms |
MGCD265 hydrochloride |
| Purity |
≥98.0% |
Storage & Handling
| Shipping |
Room temperature in continental US. May vary elsewhere. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.
